Prestige Consumer Healthcare Inc. Stock
Prestige Consumer Healthcare Inc. gained 1.830% today.
Our community is currently high on Prestige Consumer Healthcare Inc. with 4 Buy predictions and 0 Sell predictions.
As a result the target price of 61 € shows a positive potential of 36.77% compared to the current price of 44.6 € for Prestige Consumer Healthcare Inc..
Pros and Cons of Prestige Consumer Healthcare Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
M***** P*******
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prestige Consumer Healthcare Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prestige Consumer Healthcare Inc. | 1.830% | -0.463% | 0.939% | -30.645% | -19.626% | -28.333% | -3.153% |
| Apollo Medical Holdings, Inc. | -0.640% | -8.333% | -27.700% | 48.077% | 45.283% | -6.098% | -58.658% |
| Petmed Express Inc | -1.980% | -1.209% | -2.111% | -38.736% | -40.541% | -85.853% | -93.220% |
| Suzuken Co Ltd | -2.940% | -0.730% | 3.030% | 8.800% | -17.073% | 8.800% | 9.677% |
Comments
Prestige Consumer Healthcare (PBH) had its price target lowered by Canaccord Genuity Group Inc. from $86.00 to $72.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare (PBH) had its price target lowered by Oppenheimer Holdings, Inc. from $77.00 to $65.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare (NYSE:PBH) had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $82.00 to $72.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat